What is Establishment Labs Holdings Inc's share price today?
Establishment Labs Holdings Inc (ESTA) share price today is $64.35 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $67.03 and a day low of $61.46.What exchange does Establishment Labs Holdings Inc stock trade on, and under what ticker symbol?
Establishment Labs Holdings Inc stock trades on NASDAQ under the ticker symbol ESTA.What is Establishment Labs Holdings Inc's market capitalization?
Establishment Labs Holdings Inc's market capitalization is $1.82B as of November 6, 2026 at 2:29 AM IST.What is Establishment Labs Holdings Inc's price-to-earnings (P/E) ratio?
Establishment Labs Holdings Inc's price-to-earnings (P/E) ratio is N/A as of November 5, 2026.What is Establishment Labs Holdings Inc's price-to-book (P/B) ratio?
Establishment Labs Holdings Inc's price-to-book (P/B) ratio is 116.67 as of November 5, 2026.Can Indian investors buy Establishment Labs Holdings Inc shares?
Yes, You can buy Establishment Labs Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Establishment Labs Holdings Inc shares from India?
Indian investors can buy Establishment Labs Holdings Inc shares in three steps: 1. Search Establishment Labs Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Establishment Labs Holdings Inc shares for Indian investors?
Since Establishment Labs Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Establishment Labs Holdings Inc shares via Tickertape?
Indian investors can start investing in Establishment Labs Holdings Inc (ESTA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1553 shares at the current price of $64.35.
$
₹
$64.353.85% (-2.58)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
116.67
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-1.27
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
-14.56%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 10 analysts reports
Buy10 analysts
Hold0 analyst
Sell0 analyst
Price Upside
+46.4%
Earnings Growth
+22.99%
Rev. Growth
+30.17%
Company Profile
Company Profile
P/E Ratio
85.22
85.22
1Y Return
3.02%
3.02%
Buy Reco %
85.18
85.18
P/E Ratio
45.67
45.67
1Y Return
38.53%
38.53%
Buy Reco %
93.75
93.75
P/E Ratio
21.04
21.04
1Y Return
6.47%
6.47%
Buy Reco %
35.29
35.29
P/E Ratio
22.45
22.45
1Y Return
20.18%
20.18%
Buy Reco %
50.00
50.00
P/E Ratio
—
—
1Y Return
30.95%
30.95%
Buy Reco %
46.66
46.66
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$66.94Baseline
Analyst Target - 1 year
Target$98+46.4%
All values in $
2026
Current$66.94Baseline
Analyst Target - 1 year
Target$98+46.4%
All values in $
Revenue Forecast
Revenue Forecast
Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 30.17% growth, versus a trailing 3-year CAGR of 9.29%.
2025
Current$211.07Baseline
Forecast for Dec 2026
High$276.97+31.22%
Average$274.75+30.17%
Low$274+29.81%
All values in $ Million
2025
Current$211.07Baseline
Forecast for Dec 2026
High$276.97+31.22%
Average$274.75+30.17%
Low$274+29.81%
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-1.74Baseline
Forecast for Dec 2026
High$-1.18+32.18%
Average$-1.34+22.99%
Low$-1.49+14.37%
All values in $
2025
Current$-1.74Baseline
Forecast for Dec 2026
High$-1.18+32.18%
Average$-1.34+22.99%
Low$-1.49+14.37%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
| Financial Year | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44.11 | 40.22 | 44.51 | 41.37 | 51.3 | 53.78 | 64.61 | 59.87 | 67.54 | 71.99 |
Gross Profit | 28.93 | 25.71 | 30.49 | 27.80 | 35.27 | 37.69 | 45.53 | 42.33 | 47.71 | 49.71 |
| Net Income | -17.18 | -16.68 | -34.53 | -20.71 | -16.59 | -11.14 | -2.61 | -13.38 | -11.74 | -10.70 |
| Net Profit Margin | -38.94% | -41.46% | -77.57% | -50.05% | -32.34% | -20.72% | -4.04% | -22.34% | -17.39% | -14.87% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareMedical Devices
HealthcareMedical Devices
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Establishment Labs Holdings Inc | - | 116.67 | - |
| Medline Inc. Class A Common Stock | 85.22 | 2.55 | - |
| West Pharmaceutical Services Inc | 45.67 | 9.57 | 2.96 |
Price Comparison
Price Comparison
Compare ESTA with any stock or ETFCompare ESTA with any stock or ETF
Comparing from
ESTA
MDLN
WST
The 12-month consensus target implies 46.40% growth, versus a trailing 3-year CAGR of 25.42%.